PEB - Pacific Edge Ltd

[baaantom]

I think you've got your currency conversion back to front mate. USD16.6m currently equals about NZD25.5m.

A nice little top up - if it ever comes to fruition - but like most things with PEB, the prospects are bright but the reality is pretty dim.

Ahhh thats embarrassing I guess without LCD inclusion, there isn't much reality at all. With inclusion in the US guidelines plus the product code and national price (which usually come AFTER an LCD) I feel they are likely to get the LCD this year. The backstop date to hear from their LCD contractor is August so we should hear something by then.

[Balance]

Ahhh thats embarrassing I guess without LCD inclusion, there isn't much reality at all. With inclusion in the US guidelines plus the product code and national price (which usually come AFTER an LCD) I feel they are likely to get the LCD this year. The backstop date to hear from their LCD contractor is August so we should hear something by then.

I would concede that if they get LCD, PEB at 14.5c is probably the cheapest stock on the market today.

[BigBob]

I would concede that when they get LCD, PEB at 14.5c is probably the cheapest stock on the market today.

There...! Fixed that for you... ;-)

[baaantom]

There...! Fixed that for you... ;-)

Exactly. I would also add to my comments above that there most recent clinical utility evidence is very compelling. Compelling enough for most of the NZ District Health Boards to add the suite of tests into their standard practice.

[BigBob]

https://www.nzx.com/announcements/354817

Maybe that's why it's been inching upwards lately... 🙂

[Balance]

Up 50% on this news!

https://www.nzx.com/announcements/354817

Cancer diagnostics company, Pacific Edge Limited (NZX: PEB) and US healthcare provider, Kaiser Permanente, have reached agreement for the commercial use of Pacific Edge’s Cxbladder tests.

Kaiser Permanente has approved the commercial use of Cxbladder by their urologists for patients being evaluated for bladder cancer.

[Minerbarejet]

https://www.nzx.com/announcements/354817

Maybe that's why it's been inching upwards lately... 

Not bad for dead in the water.

[Balance]

Not bad for dead in the water.

Onwards and forwards to $1.00, you reckon?

[RTM]

Who knows ?
But if they can succeed...then this is a great success for New Zealand Inc.
Although I am no longer a holder... I really hope they do well.

[pierre]

Up 50% on this news!

https://www.nzx.com/announcements/354817

Cancer diagnostics company, Pacific Edge Limited (NZX: PEB) and US healthcare provider, Kaiser Permanente, have reached agreement for the commercial use of Pacific Edge’s Cxbladder tests.

Kaiser Permanente has approved the commercial use of Cxbladder by their urologists for patients being evaluated for bladder cancer.

Hmmm. Maybe someone having Humble Pie for dinner tonight?